Lapatinib plus capecitabine versus capecitabine alone for ErbB2-positive metastatic breast cancer (MBC) – Quality of Life (QOL) assessment
Year: 2008
Type: article
Authors: X. Zhou, A. Segreti, D. Cella, D. Cameron, C. Geyer, M. Amonkar, S. Stein, M. Walker
Institution: RTI International
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2018363327